Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 11, 2021

View Archived Issues

UBE-1099: a novel Keap1-Nrf2 PPI inhibitor for kidney disease

SUVN-4404091 shows efficacy in rat model of amphetamine-induced hyperlocomotion

New NMDA receptor antagonists described by Suzhou Nhwa Biomedical Technology

PharmaBlock Sciences discovers p300 and CREBBP inhibitors

SyneuRx International patents DAAO and/or 3C-like proteinase inhibitors

New GnRH-R antagonists identified at Shanghai Innofortune Biotech

XuanZhu Pharma divulges new DNA-dependent protein kinase inhibitors

Researchers develop CFTR-mutated cystic fibrosis murine model to allow gene-editing strategies

TQS-168 extends survival in mouse model of ALS

Trivalent PROTAC SIM-1 shows enhanced BET degradation and cytotoxicity

MEF2 as key regulator and potential therapeutic target for neurodegeneration

Omega Therapeutics offers pipeline and research update

9 Meters Biopharma and Gustave Roussy collaborate further on gut microbiome modulator NM-102

Monte Rosa selects MRT-2359 as first development candidate

Zika-specific therapy found to protect fetal mouse brains

Virpax announces contracts to support development and manufacturing of Envelta

Gain reports preclinical data on GT-02287 and GT-02329 for Gaucher's and GBA1 Parkinson's disease

Lennham discloses deuterated testosterone compound

BACH1 targeting has neuroprotective effects in Parkinson's disease

Biomea Fusion advances BMF-219 for leukemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...